Innocan Pharma INNPF
OTC INNPF
$1.29 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST

Innocan Pharma (INNPF) Times Interest Earned (2024 - 2025)

Updated

Innocan Pharma's Times Interest Earned came in at 37.81 for the quarter ended Dec 31, 2025, up 252.9% from 10.71 a year earlier.

Analysis

Innocan Pharma (INNPF) Times Interest Earned (2024 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Innocan Pharma's Times Interest Earned was 418.33.

  • Going back by year, Times Interest Earned was 25.45 in the year ended Dec 31, 2024 (-97.3%) and 950.75 in the year ended Dec 31, 2023.
  • The figure for the quarter ended Dec 31, 2025 represents the highest quarterly Times Interest Earned since the quarter ended Sep 30, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 28.50
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 9.20
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 5.68
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 12.87
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Innocan Pharma 5.78 Mn 1.73 Mn 4.43 Mn 37.81
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 37.81
Sep 30, 2025 -10.59
Dec 31, 2024 10.71
Sep 30, 2024 39.11
API Access

Innocan Pharma Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=INNPF&period=max&api_key=YOUR_API_KEY